PARKINSON’S DISEASE: National clinical guideline for diagnosis and management in primary and secondary care ppt

... Health and Clinical Excellence to undertake the work on this guideline. 12 Parkinson’s disease PARKINSON’S DISEASE National clinical guideline for diagnosis and management in primary and secondary ... document National Collaborating Centre for Chronic Conditions. Parkinson’s disease: national clinical guideline for diagnosis and management...

Ngày tải lên: 31/03/2014, 13:20

... are not used as a basis for making a recommendation. RCT, randomised controlled trial TYPE 2 DIABETES National clinical guideline for management in primary and secondary care (update) This is ... by the National Institute for Health and Clinical Excellence (NICE) to undertake commissions for national clinical guidelines on an annual rolling programme. Citat...

Ngày tải lên: 08/03/2014, 14:20

... characteristics in clinical presentation is inadequate in differentiating bacterial from viral acute rhinosinusitis. However, the utility of such clinical criteria for initiating empiric antimicrobial ... assessment for antimicrobial resistance and evolution of clinical responses is offered ( Figure 1). This guideline is intended for use by all primary care physicians...

Ngày tải lên: 05/03/2014, 10:20

... appreciate in the upper limbs and typically becomes apparent during testing of coordination or RAMs. The patient attempting to close the hand and extend the index finger to make a pointer for finger-nose ... Therapies in Parkinson’s Disease: Diet, Physical Therapy, and Networking 197 Padraig E. O’Suilleabhain, MB, and Susan M. Murphy, MD C. PARKINSONISM BUT NOT PARKINSON’S...

Ngày tải lên: 05/03/2014, 23:20

... ashei cultivars, principally containing delphinidin, cyanidin, peonidin, petunidin, and malvidin, increased apoptosis as determined by DNA fragmenta- tion and cysteine–aspartic acid protease, caspase-3, ... coronary, anti -in ammatory, arteries, sedative, tumor inhibition, antitumor, blood glucose lowering Anthocyanins: cyanidin, delphinidin, malvidin, pelargonidin, petunidin, and peoni...

Ngày tải lên: 25/10/2013, 05:20

... vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin ⁄ cholecystokinin, neu- rotensin and dopamine beta-hydroxylase. Neuroscience 5, 689–744. M. Westerlund et al. Expression of ADH and ... including investigations in human tissues, and that this has implications for how to interpret the role of the stud- ied enzymes in health and disease. Results The distributio...

Ngày tải lên: 16/03/2014, 11:20

... FEBS MINIREVIEW LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles Zhenyu Yue Department of Neurology and Neuroscience, Mount Sinai School of Medicine, ... cytoskeleton proteins are known as frequent ‘contaminants’ in the process of searching binding proteins, the in vivo evidence for the relation- ship between ROCO proteins and...

Ngày tải lên: 23/03/2014, 04:20

... MINIREVIEW LRRK2 in Parkinson’s disease: genetic and clinical studies from patients Udhaya Kumari 1,2 and E. K. Tan 1,2 1 Department of Neurology, Singapore General Hospital, Singapore, Singapore 2 ... WD40 domain. Because WD40 domain is involved in mediat- ing protein–protein interactions, the LRRK2 G2385R variant may impact on interactions with substrates and ⁄ or regulatory...

Ngày tải lên: 23/03/2014, 04:20

... disability, increased risk for nursing-home placement and increased mortality (Goetz and Stebbins, 1993; Biggins et al., 1992; Marder et al., 1995). Definition and Clinical Features The clinical profile ... of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology, 62,37 40. Paci, C., Thomas, A. and Onofrj, M. (2001) Amantadine for dyskinesia in patients af...

Ngày tải lên: 14/02/2014, 17:20